Defecetive Drugs: adrugrecall.com
NEWSLETTER
Sign up for our newsletter
to receive breaking news about drugs to watch
Contact A Lawyer
Near You
Contact us today for a complimentary consultation with a qualified attorney near you.
Accolate warning revision announced by FDA
-May 17, 2004
The FDA has approved an Accolate revision to the warnings and precautions sections due to the risk of hepatoxicity. Instances of life threatening liver failure have been reported to the FDA by Accolate patients. For more information on Accolate, please contact us.
view more of this month's articles
